CCL
Chemokine (C-C motif) ligand -# CXCL Chemokine (C-X-C motif) ligand-# Cyr61
Cysteine-rich protein 61, a.k.a. IGFBP-10 DLL4 Delta-like ligand 4 DPPIV Dipeptidyl peptidase IV; a.k.a., cluster of differentiation 26 (CD26) EGF Epidermal growth factor ESM-1
Endothelial cell-specific molecule-1; a.k.a. endocan FGF-1
Fibroblast growth factor-1; a.k.a. acidic FGF (aFGF) FGF-2 Fibroblast growth factor-2; a.k.a. basic FGF (bFGF) Fibroblast growth factor-7; a.k.a. keratinocyte growth factor (KGF) G-CSF Granulocyte-colony stimulating factor GM-CSF Granulocyte-macrophage-colonystimulating factor HB-EGF Heparin-binding EGF-like growth factor HGF Hepatocyte growth factor I-309 a.k.a., CCL1 and T-cell activation-3 (TCA-3) ICAM-1 Intercellular adhesion molecule-1; a.k.a. CD54 IFN-c Interferon-gamma IGF Insulin-like growth factor-1 and -2 IGFBP Insulin-like growth factor bindingprotein-1, -2, -3, -5, and -6 IL Interferon-inducible protein-10; a.k.a. CXCL10 and cytokine responsive gene-2 (CRG-2) I-TAC Interferon-inducible T-cell alpha chemoattractant; a.k. (Kleinman and Martin 2005) . It is primarily used for the in vitro culture of cells, either as an aid to cell attachment and growth or as a 3D biological gel in which cells are suspended and grown (Schuetz et al. 1988; Miyazaki et al. 2002; Kleinman and Martin 2005; Talbot et al. 2010; Nguyen-Ngoc and Ewald 2013) . The EHS tumor is propagated in vivo and the extracellular matrix-like material extracted from it is mainly comprised of laminin (*60 %), collagen IV(*30 %), nidogen (*5 %), the heparan sulfate proteoglycan perlecan (*3 %), and entactin (*1 %) (Orkin et al. 1977; Kleinman et al. 1982 Kleinman et al. , 1986 . In addition, however, Matrigel has been found to contain various other biological components including MMP-2, MMP-9, urokinase [urokinase-type plasminogen activator (uPA)], tissue-type plasminogen activator, amylase, transferrin, and clusterin (Dirami et al. 1995; Gillette et al. 2003; Kleinman and Martin 2005) . Growth factors have also been identified in Matrigel. It was shown to contain transforming growth factor beta (TGFb), EGF, IGF-1, FGF-2, PDGF, and nerve growth factor (Vukicevic et al. 1992 ; BD Biosciences Matrigel Product Data Sheet). Because of the various biological effects of these growth factors on a wide array of cell types, attempts were soon made to reduce their concentration, and ''growthfactor reduced'' Matrigel products are commercially available (Vukicevic et al. 1992 ; BD Biosciences). More recently, large scale proteomic analyses of Matrigel have been reported in an effort to qualitatively identify the less abundant proteins/peptides contained in it (Hansen et al. 2009; Hughes et al. 2010) . These efforts identified the known extracellular matrix components that comprise the bulk of Matrigel and also over one-thousand other proteins. However, nearly without exception the other proteins identified were cellular proteins that are not secretory in nature, i.e., intracellular and membrane component proteins (Hansen et al. 2009; Hughes et al. 2010) . What biologically active proteins/peptides that can be reproducibly found in Matrigel, lot-to-lot, is otherwise unreported or unknown.
In an attempt to broaden the knowledge of what biologically active proteins Matrigel contains, we have analyzed the liquid component of Matrigel (centrifrugally expressed from gelled Matrigel) using commercially available mouse specific proteome arrays that purport to define the expression of 106 separate proteins in a semi-quantitative way. The results show that Matrigel contains many more biologically active proteins than has previously been reported, and their potential influences on cells in culture, particularly, embryonic stem cells (ESC) and induced pluripotent stem cells (iPCS), is discussed.
Materials and methods
Matrigel basement-membrane-matrix liquid component preparation Four separate lots of Matrigel basement membrane matrix (catalog no. 356234) were obtained from BD Biosciences (Bedford, MA, USA). After thawing on ice, two 900 ll aliquots of Matrigel were gelled at 37°C in two 1.5 ml ultracentrifuge tubes (Beckman Coulter, Inc.; Danvers, MA, USA). The supernatants were collected from the compressed gel after centrifugation at 125,0009g for 30 min at 4°C. The gel was then subjected to a second centrifugation at 125,0009g for 30 min at 4°C, and supernatants were again collected and combined with those from the first centrifugation. From each 1.8 ml sample of Matrigel approximately 1.4 ml of total supernatant could be collected.
Proteome antibody array analysis
Semi-quantitative protein analysis of four independent lots of Matrigel supernatant, diluted 1:3, was performed according to the manufactures instructions on three protein antibody arrays that detect a total of 106 mouse growth factors, chemokines, extracellular matrix factors, and other biologically active proteins (R&D Systems, Inc., Minneapolis, MN, USA; Cat. No. ARY013, ARY006, and ARY015). The arrays' capture antibodies (antibodies to the specified proteins), and positive and negative controls, are printed in duplicate (the results therefore being the average of two reactions) on nitrocellulose membranes and four membranes in total are included. The arrays' chemiluminescent autoradiographs ( Fig. 1) were measured by densitometry, corrected for background density, and expressed relative to each array's positive controls (ImageQuant TL Software, GE Healthcare, Piscataway, NJ, USA).
Results
Semi-quantitative protein analysis of four separate lots of Matrigel was performed and representative array results are shown in Fig. 1 . The densitometry values ± their standard deviation are listed in Table 1 by array designation (''angiogenesis'', ''cytokine'', or ''adipokine'') for a total of 106 mouse growth factors, chemokines or other biologically active proteins. The coordinates of each target protein are listed in the first column of Table 1 , and their specific locations on the arrays are also available on-line from R&D Systems, Inc.
The strongest detection signals (densitometry value C 50) among the growth factors/cytokines assayed were found for IGFBP-1, IGFBP-3, LIF, platelet factor 4, PlGF-2, and VEGF. A moderate positive response (densitometry values approximately between 20 and 49) was found for cyr61, IGFBP-2, IGFBP-6, IL-1ra, and NOV. Low, but detectable, responses occurred for aFGF, IL-13, IL-23, M-CSF, and VEGF-B (densitometry values approximately between 5 and 19). The chemkines assayed by the arrays showed high positive detection for MIG and serpin E1 while moderate reactivity was found for IP-10, MCP-1, and MCP-5, and low, but detectable, responses occurred for CXCL16, I-TAC, and MIP-1a. Among the other biologically active proteins assayed, high positive detection was found for adiponectin, C5a, endocan, lipocalin-2, sICAM-1, MMP-3, and TIMP-1 while moderate reactivity was found for C-reactive protein, coagulation factor III, endoglin, endostatin/ collagen XVIII, endothelin-1, ICAM-1, MMP-9, osteopontin, pentraxin-3, and RANTES, and low, but detectable, responses occurred for fetuin A, MMP-8, pentraxin-2, RBP4, resistin, and TIMP-4.
Discussion
The proteome array results indicated the consistent presence of numerous secreted/soluble proteins present in four independent lots of commercially obtained EHS tumor extract, i.e., Matrigel (BD Biosciences). The results also highlight the apparent absence of several dozen other secreted/soluble proteins in Matrigel (Table 1) . Despite recent proteomic analyses of Matrigel employing mass spectroscopy (Hansen et al. 2009; Hughes et al. 2010) , the immunoassay analysis presented here identified many secreted/soluble proteins not previously identified in Matrigel, and did so in a semi-quantitative manner. Many of the newly identified proteins have various and well described effects on cell growth, differentiation, or maintenance in general. Because of the wide interest in stem cell biology and the frequent use of Matrigel in various in vitro stem cell assays, some discussion of the result in this context is exemplary and pertinent (Xu et al. 2001; Philp et al. 2005; Kleinman and Martin 2005; Ma et al. 2008; Uemura et al. 2010) . Under the category of growth factors/cytokines, the proteome arrays identified relatively high levels of IGFBP-1 (mean score of 72 and 125 units on separate arrays; relative to the arrays internal negative and positive controls), IGFBP-2 (41 and 63 units on separate arrays), IGFBP -3 (134 and 231 units on separate arrays), and IGFBP-6 (47 units), LIF (95 units), platelet factor-4 (124 units), and PlGF-2 (112 units). Insulin-like growth factor binding proteins sustain and mediate the action of IGF-1 and IGF-2, and IGF-1 signaling was found to be necessary for maintenance of human ESC (hESC; Wang et al. 2007 ). Also in a stem cell context, IGFBP-3, which had the highest response of the IGFBPs detected in Matrigel, is involved in various stem cell processes including vascular endothelial cell differentiation from hematopoietic endothelial precursor cells (Chang et al. 2007 ), inhibition of neural progenitor cells proliferation (Kalluri and Dempsey 2011) , and modulation of liver regeneration from the hepatic stem cell compartment (Steiger-Luther et al. 2010) . Besides the detection of IGFBP-1, -2, -3, and -6 with the proteome array, preliminary ELISA data also indicated that Matrigel contains[1 ng/ml IGFBP-4 (unpublished data). Thus, in using Matrigel, it should be understood that it will probably have effects on IGF-1/IGF-2 signal activation. Leukemia inhibitory factor is a key factor in maintaining the undifferentiated state of mouse ESC (mESC; Pease et al. 1990 ). It's presence in Matrigel, therefore, could have significant effects on assessments of mESC growth and differentiation that should be taken into consideration when using Matrigel and mESC together (Greenlee et al. 2005; Zhou et al. 2010; Massumi et al. 2012) . Platelet factor-4 (PF4) is a marker of megakaryocytes and has angiostatic effects (Strieter et al. 1995; Pick et al. 2013) . Its relatively high levels in Matrigel might affect hematopoietic differentiation and vasculogenesis from ESC (Gerecht-Nir et al. 2003) . Conversely, PlGF-2 is a positive factor for angiogenesis and endothelial cell proliferation via its binding to the VEGF receptor, and its presence in Matrigel would also be expected to influence Matrigelbased stem cell assays involving blood cell formation and vasculogenesis (Zhou et al. 2013 ). Finally, VEGF itself was detected as a high responder, and again, would mean that Matrigel could, in and of itself, affect ESC hematopoiesis and vasculogenesis, and hematopoietic stem cell differentiation, growth or survival (Nakayama et al. 1998; Gerber et al. 2002; Gerecht-Nir et al. 2003) . Chemokines that were indicated to be at high levels in Matrigel by the proteome array results were MIG (145 units) and serpin E1 (160 and 92 units in separate arrays), and some others, MCP-1 (96, 44, and 30 units in separate arrays) and , were detected at lower levels. These and other chemokines are being found to play important roles in stem cell biology. For example, it was recently shown that MCP-1 (a.k.a. CCL2) stimulated core ESC inducing factors Klf4, Nanog, Sox2, and Tbx3, and, that in conjunction with LIF, maintains pluripotency in mESC and mouse induced pluripotent stem cells (miPSC; Hasegawa et al. 2011) . Other reports indicated chemokine participation in stem cell-mediated angiogenesis and cardiogenesis (Chamberlain et al. 2011; Tamura et al. 2011; Bronckaers et al. 2013; Lee et al. 2013) .
High positive detection was found for adiponectin (92 units), C5a (127 units), endocan (106 units), lipocalin-2 (142 units), sICAM-1 (97 units), MMP-3 (101 units), and TIMP-1 (241, 119, and 27 units from three separate arrays) in Matrigel. The elevated levels of these functionally diverse proteins in Matrigel may be caused by the effects of the Matrigel-source-tumor on the host mouse's physiology as it grows in the body. That is, these proteins, with the exception of adiponectin, are inflammation related and tissue integrity/ remodeling related. Similarly, the other disparate proteins found in Matrigel at moderately high levels, i.e., C-reactive protein (44 units), coagulation factor III (37 units), endoglin (22 units), endostatin/collagen XVIII (38 units), endothelin-1 (29 units), ICAM-1 (44 units), IL-1ra (44 units), MMP-9 (37 units), osteopontin (34 units), pentraxin-3 (23 and 16 units in separate arrays), and RANTES (89 and 47 units in separate arrays) are also involved with inflammation and tissue integrity/remodeling. Be that as it may, some of these proteins can have profound effects on ESC maintenance, growth, and differentiation. For example, matrix remodeling by metalloproteinases (MMP) can support self-renewal of ESC, presumably by mobilizing pluripotency factors sequestered in the surrounding cell matrix (Przybyla et al. 2013) . Another example is the potentiating role of MMP-3 in cardiac muscle differentiation in ESC embryoid bodies (Hong et al. 2010) . Finally, it is interesting to note the recent report highlighting a connection between the activation of innate cellular inflammatory processes and its enhancement of nuclear reprogramming (Lee et al. 2012) . Here, activation of toll-like receptors (TLR), particularly TLR3, led to epigenetic remodeling that render a cell's chromatin more accessible to reprogramming factors and higher reprogramming efficiency. Although very speculative, some of the downstream inflammatory effector molecules linked to TLR activation, and that are found in Matrigel, such as C-reactive protein, endothelin-1, ICAM-1, IL-1ra, pentraxin-3, and RANTES might have a similar effect on nuclear reprogramming. What is sure, however, is that the presence of these inflammatory and cellmatrix remodeling proteins in Matrigel should be taken into account in biological assays using Matrigel because of their wide spread effects on a variety of cell types (Albini et al. 1987; Draper et al. 2004; Kleinman and Martin 2005; Lo et al. 2012) .
Some previously reported growth factor components of Matrigel were not detected by the proteome arrays, i.e., FGF-2, IGF-1, PDGF, and EGF. This may reflect a factors low level in Matrigel, i.e., *1 pg/ml for FGF-2 and *3-12 pg/ml for PDGF (Vukicevic et al. 1992 ; BD Biosciences), and the limits of detection of the proteome array. However, proteome array sensitivity would not seem to explain the lack of detection for EGF and IGF-1 since these factors were previously reported to be in Matrigel in nanogram amounts; 3-4 ng/ml for EGF and 6-7 ng/ml (Vukicevic et al. 1992) or even 15 ng/ml for IGF-1 (BD Biosciences). We have previously noted some dissimilar results when comparing proteome array results to the results obtained from commercially available ELISA when measuring growth factors in conditioned cell culture medium (Talbot et al. 2012) .
Other apparent anomalies may also be present in the results from the proteome arrays. Across the three arrays, some of the same proteins were targeted on different arrays. In comparing these instances, there were some pronounced differences in the resulting signal, e.g., TIMP-1, IGFBP-1 and -3, and RANTES (Table 1 ). The small differences between the arrays' positive controls do not explain the wide differences found for these and a few other duplicated proteins on the arrays. This would suggest an inconsistency of the array proteome technology or that separate arrays are using different capture antibodies for the same protein target. Whether this variation is a quality control issue or illustrates the semi-quantitative nature of the proteome array data, this indicates that the data presented here need independent verification by alternative and more quantitative protein detection methods.
